Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$13.05 +0.94%

+$0.15 today

Market cap
$331.67M
Beta
0.48
P/E (TTM)
9.3
EPS (TTM)
$1.22
52W Low $11.98High $20.56

Volume 0.04M

Average 0.03M

CPH.TO Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Cipher Pharmaceuticals Inc.TSX: CPH.TO

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses remains negative

Q1 FY2026 other income / expenses was -$635.41K, compared with -$587K a year earlier. Trailing-twelve-month other income / expenses was $479.91K.

Context

  • Other income / expenses amounted to 1.3% of revenue in FY2025, down 13.4 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly other income / expenses holds near -$635.41K or moves back toward the trailing-twelve-month quarterly average of $119.98K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$635.41K-252.3% QoQ
Last fiscal yearDec 2025
$661.38K+113.5% YoY
LTMMar 2026
$479.91K+108.4% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.2%——
1 year+113.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
661.38K USD
Year-over-year change
+113.5%

Other Income / Expenses vs competitors

How CPH.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +108.4% is the 2nd highest of 8, against a peer median of -16.3%.
  • Other income / expenses amounts to 0.9% of revenue for CPH.TO, versus a peer median of 24.4%.
CPH.TO Competitors
Other Income / Expenses for CPH.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$95.89M CAD+521.3%—30.1%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$67M CAD+65.1%—24.4%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$479.91K USD+108.4%—0.9%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$2.71M USD-29.7%—5.3%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026-CA$5.89M CAD-161.3%—1.2%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$26.64M CAD-164.5%—964.8%
TSND.TOTerrAscend Corp.LTM Mar 2026-$38.41M USD-16.3%—14.7%
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$189.78M CAD+60.5%—61.0%
Peer median (excluding CPH.TO) —-16.3%—24.4%

Competitors are the stored peer set for CPH.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue21.94M20.68M21.16M33.36M51.33M
Cost of Revenue3.68M3.99M4.07M9.26M17.56M
Gross Profit18.26M16.68M17.09M24.1M33.77M
Gross Margin83.2%80.7%80.8%72.2%65.8%
Research & Development88K98K139K021.37K
Selling, General & Admin5.11M4.4M5.43M12.24M16.3M
Operating Expenses6.45M5.63M5.56M16.26M16.97M
Depreciation & Amortization701K989K1.23M4.02M7.23M
EBITDA13.66M12.04M11.53M11.87M24.1M
EBITDA Margin62.2%58.2%54.5%35.6%46.9%
Operating Income11.82M12.04M11.53M7.85M16.8M
Operating Margin53.9%58.2%54.5%23.5%32.7%
Interest Income12K464K1.87M330K0
Interest Expense92K0001.19M
Other Income / Expenses(2M)(560K)1.15M(4.89M)661.38K
Income Before Tax11.06M11.48M12.68M2.96M17.46M
Pre-Tax Margin50.4%55.5%59.9%8.9%34.0%
Income Tax Expense3.3M(15.16M)(7.7M)(8.59M)(10.34M)
Net Income7.76M26.64M20.38M11.55M27.81M
Net Margin35.4%128.8%96.3%34.6%54.2%
EPS (Basic)0.291.060.800.471.09
EPS (Diluted)0.291.040.800.471.07
Weighted Avg Shares26.6M25.13M25.48M24.72M25.48M
Weighted Avg Shares (Diluted)26.83M25.59M25.42M24.57M25.99M

Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Intrinsic Alpha fair value

Locked

Current Price

$13.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.